HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics Plc (NBRV), sold 90,909 shares at $10.53 ($956K) on 2017-07-14, disclosed to the SEC on 2017-07-18.
Open-market sale of $956k NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.53 | 21,055 | $222K | 23.2% |
| 2 | $10.53 | 21,055 | $222K | 23.2% |
| 3 | $10.50 | 47,460 | $498K | 52.1% |
| 4 | $10.50 | 1,339 | $14K | 1.5% |
| Total | $10.52 avg | 90,909 | $956K | 100% |
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |